European markets on track to continue growth pending anticipated rate cuts
Europe’s biggest markets are on course to continue their recent growth as central banks worldwide prepare to reduce interest rates. This comes after Germany adjusted its 2019 and 2020 economic growth forecasts downwards. Investors are now anticipating a 10 basis point rate cut from the ECB before the end of this year, with the US Federal Reserve expected to follow suite following a sharp slowdown in job growth during May. Factors likely to hold back European markets include investor cautiousness over the uncertainty surrounding the identity of the next British Prime Minister and the increasing probability of a “no deal” Brexit. Turning our focus to individual markets in the region, the situation on the French stock market will to a large extent be determined by corporate news. In recent weeks, investors’ attention has been firmly fixed on Renault as they await any new developments from the automaker. French Minister of Economy and Finance Bruno Le Maire has announced that the country is prepared to reduce its stake in Renault in a bid to shore up its alliance with Japanese car manufacturer Nissan. Renault is already party to an alliance agreement with Japanese firms Nissan and Mitsubishi, but the partnership has been under fire since the arrest last November of alliance chief Carlos Ghosn.
Andrey Voytkiv, Financial scout at Libertex.
Topic: Libertex launches Litecoin and Bitcoin Cash margin trading - page 2. (Read 1275 times)
European markets under negative pressure from all sides
The European stock markets are under intense pressure from a whole raft of negative factors, both internal and external. For instance, the prospects of a resolution to the US-China trade conflict remain hazy at best, which is negatively impacting the entire world economy. This comes after China made a statement that it would be prepared to limit rare earth metal exports to the US in response to US restrictions on Chinese exports. Another worry weighing on Europe's indices is Italy's budget. Investors fear that the European Commission might fine Italy 3.5 billion euros in light of its national debt situation. The EU has announced that it strongly recommends Italy reassess its budget stance, claiming that the country's decision to increase its deficit has only harmed the Mediterranean nation's economy, which now has the slowest growth rate in the region. And who could forget Brexit? Britain's departure from the EU still remains one of the biggest challenges facing the European markets. The issue has seen a political dogfight emerge in the UK in which the Brexit Party — which wants Brexit at any cost — seems to have come out on top. This comes as a number of political powers are predicting that a no deal Brexit would have serious negative consequences for both the British and EU economies.
The European stock markets are under intense pressure from a whole raft of negative factors, both internal and external. For instance, the prospects of a resolution to the US-China trade conflict remain hazy at best, which is negatively impacting the entire world economy. This comes after China made a statement that it would be prepared to limit rare earth metal exports to the US in response to US restrictions on Chinese exports. Another worry weighing on Europe's indices is Italy's budget. Investors fear that the European Commission might fine Italy 3.5 billion euros in light of its national debt situation. The EU has announced that it strongly recommends Italy reassess its budget stance, claiming that the country's decision to increase its deficit has only harmed the Mediterranean nation's economy, which now has the slowest growth rate in the region. And who could forget Brexit? Britain's departure from the EU still remains one of the biggest challenges facing the European markets. The issue has seen a political dogfight emerge in the UK in which the Brexit Party — which wants Brexit at any cost — seems to have come out on top. This comes as a number of political powers are predicting that a no deal Brexit would have serious negative consequences for both the British and EU economies.
European markets weigh up May’s resignation.
European investors are still assessing the medium-to-short term implications of British PM Theresa May’s announcement that she will be stepping down come 7 June. The current favourite in the race for Number 10 is former Foreign Minister Boris Johnson. Market insiders believe that May’s resignation could help speed up the process of the government securing cross-party support for any final EU withdrawal plan. This comes at a time when the risk of a “no deal” Brexit is looming increasingly large with each day that passes. Elsewhere, European investors are also concerned that May's departure will make it difficult for the Bank of England to maintain its high base rate policy, thus increasing the likelihood of a reduction. Another key area of interest is the still-unresolved US-China trade conflict, which has only been intensifying of late. Despite US President Donald Trump's statement that the US's allegations of irregularities against Chinese company Huawei can be resolved by way of a trade deal, investors are still worried that the parties will be unable to reach any kind of agreement. The next meeting between the two countries' respective heads of state is set to take place as part of the G20 meeting in Japan next month. In regional corporate news, we have received reports that a Renault and Fiat Chrysler merger could be on the cards. In fact, the two companies are allegedly discussing the terms of the potential fifty-fifty merger as we speak.
European investors are still assessing the medium-to-short term implications of British PM Theresa May’s announcement that she will be stepping down come 7 June. The current favourite in the race for Number 10 is former Foreign Minister Boris Johnson. Market insiders believe that May’s resignation could help speed up the process of the government securing cross-party support for any final EU withdrawal plan. This comes at a time when the risk of a “no deal” Brexit is looming increasingly large with each day that passes. Elsewhere, European investors are also concerned that May's departure will make it difficult for the Bank of England to maintain its high base rate policy, thus increasing the likelihood of a reduction. Another key area of interest is the still-unresolved US-China trade conflict, which has only been intensifying of late. Despite US President Donald Trump's statement that the US's allegations of irregularities against Chinese company Huawei can be resolved by way of a trade deal, investors are still worried that the parties will be unable to reach any kind of agreement. The next meeting between the two countries' respective heads of state is set to take place as part of the G20 meeting in Japan next month. In regional corporate news, we have received reports that a Renault and Fiat Chrysler merger could be on the cards. In fact, the two companies are allegedly discussing the terms of the potential fifty-fifty merger as we speak.
Canadian cannabis stocks continue to grow on Tilray's financials
The majority of Canada's biggest cannabis producers experienced strong price growth this Wednesday after Tilray (TLRY) reported better than expected Q1 sales growth. According to its quarterly report, the company's sales totaled CAD 23 million, which constitutes a rise of 195% compared with a year ago.
In addition to the above, Tilray also announced that it plans to start purchasing cannabis from third-party producers but is yet to find a supplier capable of satisfying its quality requirements.
The market was unshaken even by Aurora Cannabis's (ACB) quarterly report, which revealed worse than expected Q1 sales. As the company itself noted, its net sales for that period totaled CAD 65.1 million, which represents a 20% increase on the previous quarter. Nevertheless, investors had expected that figure to be more in the region of CAD $68.7 million. Meanwhile, the company reported a net loss of CAD $160.2 million, which represents and improvement on last quarter.
Our financial scouts predict that Tilray's most recent quarterly report will give Canadian cannabis stocks the boost they need to continue their current growth. With this mind, they are forecasting share price increases for all the major producers, with Aurora Cannabis, Tilray and Canopy Growth (CGC) set to rise to $8.5-9, $49.5 and $46 respectively. Meanwhile, they see Aphria (APHA) and Cronos (CRON) up to $7.5 and "$15.5 respectively.
The majority of Canada's biggest cannabis producers experienced strong price growth this Wednesday after Tilray (TLRY) reported better than expected Q1 sales growth. According to its quarterly report, the company's sales totaled CAD 23 million, which constitutes a rise of 195% compared with a year ago.
In addition to the above, Tilray also announced that it plans to start purchasing cannabis from third-party producers but is yet to find a supplier capable of satisfying its quality requirements.
The market was unshaken even by Aurora Cannabis's (ACB) quarterly report, which revealed worse than expected Q1 sales. As the company itself noted, its net sales for that period totaled CAD 65.1 million, which represents a 20% increase on the previous quarter. Nevertheless, investors had expected that figure to be more in the region of CAD $68.7 million. Meanwhile, the company reported a net loss of CAD $160.2 million, which represents and improvement on last quarter.
Our financial scouts predict that Tilray's most recent quarterly report will give Canadian cannabis stocks the boost they need to continue their current growth. With this mind, they are forecasting share price increases for all the major producers, with Aurora Cannabis, Tilray and Canopy Growth (CGC) set to rise to $8.5-9, $49.5 and $46 respectively. Meanwhile, they see Aphria (APHA) and Cronos (CRON) up to $7.5 and "$15.5 respectively.
Pinterest: the perfect picture for Libertex traders
Following the recent incorporation of Lyft to its platform, Libertex continues to expand the list of assets for its clients. Today, the Libertex trading platform announces the launch of CFDs (contracts for difference) for Pinterest (PINS), valued at $10 bn after the IPO that took place this April 17th, 2019.
The IPO price, initially set at a range of $15 to $17, quickly moved on to $19, proving the interest of investors since the very first hours, and it’s easy to understand why just having a look at some key facts about the company founded in 2010 by Ben Silbermann, a former Google employee, and Evan Sharp, ex designer at Facebook:
• 250 million users every month, of which 83% are women who make 80% of total volume of purchases.
• In the US, the site is used for purchasing goods more often than any other social media.
• It is a perspective platform both for advertising and retail business with its own solutions for e-commerce.
At present, the rate of increase in Pinterest revenues amounts to 60% and given the growth forecast for digital ad market, Pinterest may become a very alluring candidate for investments.
Sign up for free and be the first to buy Pinterest shares
About Libertex:
Libertex is an international brand with a twenty year history in financial markets and online commerce. Libertex provides investors with access to trading stocks, currencies, indices, commodities, gold, oil, gas and many other financial instruments. The Libertex team has more than 2,200,000 customers in Latin America, Europe and Asia owing to its first-class service. Libertex has more than 150 commercial instruments. In 2016, Libertex was recognized by Forex EXPO Awards as the best trading platform; and Global Banking and Finance Review named it the best trading application in the EAEU. In 2017-2018 Libertex was announced as Best trading application and Best cryptocurrency broker by Forex Awards.
Cannabis stocks down on corporate news
According to Libertex's sources, shares in major Canadian cannabis producers are in decline after Valens GroWorks posted zero earnings for last quarter. Over the previous reporting period, the company in fact recorded losses of $6.4 million, which is almost double the figure reported a year ago. However, this situation was somewhat eased by reports that the company had signed a multi-year extraction services agreement with Hexo that would see the latter supply Valens GroWorks with an annual minimum of 30 tonnes of cannabis.
There was more positive news for the market, too, as an Alabama Senate committee approved a bill to permit patients over the age of 19 to purchase medical cannabis freely.
Financial scouts predict that cannabis stocks will likely continue on their current downtrend over the short term as they look to bounce back from Valens GroWorks's recent poor results. They forecast share price drops for all the major producers, with Canopy Growth (CGC) set to fall to $47.5-48 and Aurora Cannabis (ACB) to $8-9. Meanwhile, they see shares in Tilray (TLRY) down below $51, with Cronos (CRON) and Aphria (APHA) expected to slide to below $16 and $7 respectively.
According to Libertex's sources, shares in major Canadian cannabis producers are in decline after Valens GroWorks posted zero earnings for last quarter. Over the previous reporting period, the company in fact recorded losses of $6.4 million, which is almost double the figure reported a year ago. However, this situation was somewhat eased by reports that the company had signed a multi-year extraction services agreement with Hexo that would see the latter supply Valens GroWorks with an annual minimum of 30 tonnes of cannabis.
There was more positive news for the market, too, as an Alabama Senate committee approved a bill to permit patients over the age of 19 to purchase medical cannabis freely.
Financial scouts predict that cannabis stocks will likely continue on their current downtrend over the short term as they look to bounce back from Valens GroWorks's recent poor results. They forecast share price drops for all the major producers, with Canopy Growth (CGC) set to fall to $47.5-48 and Aurora Cannabis (ACB) to $8-9. Meanwhile, they see shares in Tilray (TLRY) down below $51, with Cronos (CRON) and Aphria (APHA) expected to slide to below $16 and $7 respectively.
European investors concerned by global economic development prospects
Investors in Europe continue to scrutinise the financial statements of major US corporations amid growing concerns regarding the global economy’s future development prospects following weak economic data coming out of both Europe and Asia.
With trade talks with China looking set to resume over the week ahead, many investors are worried about the Asian giant’s long-term economic policy. As it looks to stimulate economic growth, fears of excess cash in the economy leading to a financial bubble will most likely see the People's Bank of China resist the urge to make further cuts to its reserve requirement ratio this year.
In other news, Britain’s departure from the European Union remains a hot topic for investors on the Old Continent as the latest Brexit plan negotiations end in deadlock. Elsewhere, European investors continue to monitor world oil price movements after the US announced its decision to scrap all exemptions from sanctions on importers of Iranian oil. However, financial scouts report that the commodity's price is being held in check by recent information claiming that the US has increased its oil reserves.
Investors in Europe continue to scrutinise the financial statements of major US corporations amid growing concerns regarding the global economy’s future development prospects following weak economic data coming out of both Europe and Asia.
With trade talks with China looking set to resume over the week ahead, many investors are worried about the Asian giant’s long-term economic policy. As it looks to stimulate economic growth, fears of excess cash in the economy leading to a financial bubble will most likely see the People's Bank of China resist the urge to make further cuts to its reserve requirement ratio this year.
In other news, Britain’s departure from the European Union remains a hot topic for investors on the Old Continent as the latest Brexit plan negotiations end in deadlock. Elsewhere, European investors continue to monitor world oil price movements after the US announced its decision to scrap all exemptions from sanctions on importers of Iranian oil. However, financial scouts report that the commodity's price is being held in check by recent information claiming that the US has increased its oil reserves.
Shares of cannabis producing companies continue to soar on the back of Canopy Growth deal with American company.
Since Friday, shares of some of the largest Canadian cannabis producers are rising in price due to Canopy Growth (CGC) announcing an agreement on merging with American Acreage Holdings.
Canopy Growth received the right to purchase all shares of the American company for $ 3.4 billion as soon as selling and producing cannabis will be legalized in the US. The Canadian company has already made an advance of $ 300 million. As a result of this transaction, Canopy Growth will be able to begin full-scale operations in the American market at the nearest time.
Currently, the global market of legal production and sales of cannabis is estimated at $ 7.7 billion per year. As financial predicted by experts, by 2021 the market will grow up to $ 21 billion - an increase of 60% is expected. Thus, the company's access to new markets is a very good factor for its stock quotes’ growth.
It can be expected that in the near future, shares of the largest cannabis producers in Canada will show positive trends, playing back to the positive news about the Canopy Growth deal with the US company. Shares of Aphria (APHA) can rise in price up to 8-8.5 dollars, Aurora Cannabis (ACB) - up to 9.5 dollars, Cronos Group (CRON) - up to 16-16,5 dollars, Tilray Inc. (TLRY) - up to 49-49,5 dollars, and the Canopy Growth (CGC) itself - up to 45-45,5 dollars.
Since Friday, shares of some of the largest Canadian cannabis producers are rising in price due to Canopy Growth (CGC) announcing an agreement on merging with American Acreage Holdings.
Canopy Growth received the right to purchase all shares of the American company for $ 3.4 billion as soon as selling and producing cannabis will be legalized in the US. The Canadian company has already made an advance of $ 300 million. As a result of this transaction, Canopy Growth will be able to begin full-scale operations in the American market at the nearest time.
Currently, the global market of legal production and sales of cannabis is estimated at $ 7.7 billion per year. As financial predicted by experts, by 2021 the market will grow up to $ 21 billion - an increase of 60% is expected. Thus, the company's access to new markets is a very good factor for its stock quotes’ growth.
It can be expected that in the near future, shares of the largest cannabis producers in Canada will show positive trends, playing back to the positive news about the Canopy Growth deal with the US company. Shares of Aphria (APHA) can rise in price up to 8-8.5 dollars, Aurora Cannabis (ACB) - up to 9.5 dollars, Cronos Group (CRON) - up to 16-16,5 dollars, Tilray Inc. (TLRY) - up to 49-49,5 dollars, and the Canopy Growth (CGC) itself - up to 45-45,5 dollars.
Libertex Launched Lyft Trading
Igor Galkin, Head of Global Business Development and Sales at Libertex Group, said, “Lyft held an IPO at the end of March, 2019. Its shares are one of the most interesting instruments of this season. We’re glad to offer our clients CFD for Lyft shares and open new trading opportunities for them.”
CFD on Lyft have a huge potential for effective trading because of two key reasons: first, they allow traders to diversify their trading strategies, and second, after the IPO they are quite volatile. Long-term investors can also find Lyft to be of interest, seeing as there is a good potential for share price growth.
Lyft shares will be available on the Libertex trading terminal starting April, 2019.
About Libertex:
Libertex is an international brand with a twenty year history in financial markets and online commerce. Libertex provides investors with access to trading stocks, currencies, indices, commodities, gold, oil, gas and many other financial instruments. The Libertex team has more than 2,200,000 customers in Latin America, Europe and Asia owing to its first-class service. Libertex has more than 150 commercial instruments. In 2016, Libertex was recognized by Forex EXPO Awards as the best trading platform; and Global Banking and Finance Review named it the best trading application in the EAEU. In 2017-2018 Libertex was announced as Best trading application and Best cryptocurrency broker by Forex Awards.
Igor Galkin, Head of Global Business Development and Sales at Libertex Group, said, “Lyft held an IPO at the end of March, 2019. Its shares are one of the most interesting instruments of this season. We’re glad to offer our clients CFD for Lyft shares and open new trading opportunities for them.”
CFD on Lyft have a huge potential for effective trading because of two key reasons: first, they allow traders to diversify their trading strategies, and second, after the IPO they are quite volatile. Long-term investors can also find Lyft to be of interest, seeing as there is a good potential for share price growth.
Lyft shares will be available on the Libertex trading terminal starting April, 2019.
About Libertex:
Libertex is an international brand with a twenty year history in financial markets and online commerce. Libertex provides investors with access to trading stocks, currencies, indices, commodities, gold, oil, gas and many other financial instruments. The Libertex team has more than 2,200,000 customers in Latin America, Europe and Asia owing to its first-class service. Libertex has more than 150 commercial instruments. In 2016, Libertex was recognized by Forex EXPO Awards as the best trading platform; and Global Banking and Finance Review named it the best trading application in the EAEU. In 2017-2018 Libertex was announced as Best trading application and Best cryptocurrency broker by Forex Awards.
Shares of cannabis growers moved to consolidation
Shares of Canadian cannabis producers on Friday do not show a single dynamic against the backdrop of hopes for a possible easing of legislation in the United States. At the same time, it can be noted that the market took some breathing space after substantial growth in the first quarter, investors are waiting for any significant corporate news events, in this case there could be a chance to see a new rally in the market.
A document proposed by a number of US senators that proposes making some legislative exceptions for banks working with the cannabis industry provided welcome news for the market. The Association of American Bankers has already supported this project.
Additional support for Aurora Cannabis (ACB) securities came after the announcement that it hired investment banker Carey Squires to work on the company's global development. In addition, in Germany, Aurora Cannabis won 5 lots at auction for the production of medical cannabis. The same lot was won by the company's competitor - Aphria Inc. (APHA). Now companies can grow 200 kilograms of cannabis in these areas per year.
However, the unfavourable news for Canopy Growth (CGC) is the poor quarterly reporting by Constellation Brands, which previously invested $4 billion in Canopy,
According to forecast financial scouts, some consolidation will continue in this market segment in the near future. Aurora Cannabis shares could rise in price to 9.5 dollars, Tilray (TLRY) - up to 61.5 dollars, Aphria - up to 10.5 dollars. Paper Canopy Growth at the same time could be reduced in price to $43, and Cronos (CRON) - up to $18.
Shares of Canadian cannabis producers on Friday do not show a single dynamic against the backdrop of hopes for a possible easing of legislation in the United States. At the same time, it can be noted that the market took some breathing space after substantial growth in the first quarter, investors are waiting for any significant corporate news events, in this case there could be a chance to see a new rally in the market.
A document proposed by a number of US senators that proposes making some legislative exceptions for banks working with the cannabis industry provided welcome news for the market. The Association of American Bankers has already supported this project.
Additional support for Aurora Cannabis (ACB) securities came after the announcement that it hired investment banker Carey Squires to work on the company's global development. In addition, in Germany, Aurora Cannabis won 5 lots at auction for the production of medical cannabis. The same lot was won by the company's competitor - Aphria Inc. (APHA). Now companies can grow 200 kilograms of cannabis in these areas per year.
However, the unfavourable news for Canopy Growth (CGC) is the poor quarterly reporting by Constellation Brands, which previously invested $4 billion in Canopy,
According to forecast financial scouts, some consolidation will continue in this market segment in the near future. Aurora Cannabis shares could rise in price to 9.5 dollars, Tilray (TLRY) - up to 61.5 dollars, Aphria - up to 10.5 dollars. Paper Canopy Growth at the same time could be reduced in price to $43, and Cronos (CRON) - up to $18.
Shares of cannabis producers may rise on a possible ETF launch.
Shares of Canadian cannabis growers on Wednesday were mostly slightly lower in price, with the exception of Canopy Growth (CGC), which added about 1.6%.
At the same time, the sector’s stocks were able to grow a little on the positive news that a large investment fund from Toronto Evolve Funds Group, whose assets amount to more than $300 million, is going to launch an ETF for cannabis producers' shares.
However, the good news for Aurora Cannabis (ACB) could be the message that the company has started selling hemp oil to Germany and
plans to become one of the largest suppliers of raw materials outside North America.
Despite the fact that while shares of cannabis producers are mostly ignoring all this positive news, in the short term they still have good chances for growth.
For example, Canopy Growth stocks could climb to $44-44.5, Aurora Cannabis - up to $9.5, Aphria (APHA) - up to $10-10.5, Cronos (CRON) - up to $19, and Tilray shares (TLRY) - up to $64-64.5.
Shares of Canadian cannabis growers on Wednesday were mostly slightly lower in price, with the exception of Canopy Growth (CGC), which added about 1.6%.
At the same time, the sector’s stocks were able to grow a little on the positive news that a large investment fund from Toronto Evolve Funds Group, whose assets amount to more than $300 million, is going to launch an ETF for cannabis producers' shares.
However, the good news for Aurora Cannabis (ACB) could be the message that the company has started selling hemp oil to Germany and
plans to become one of the largest suppliers of raw materials outside North America.
Despite the fact that while shares of cannabis producers are mostly ignoring all this positive news, in the short term they still have good chances for growth.
For example, Canopy Growth stocks could climb to $44-44.5, Aurora Cannabis - up to $9.5, Aphria (APHA) - up to $10-10.5, Cronos (CRON) - up to $19, and Tilray shares (TLRY) - up to $64-64.5.
Shares of cannabis producers rise after falling after Cronos reporting.
Shares of Canadian cannabis manufacturing companies on Friday mostly rose as part of the correction to a rather serious fall, which followed the publication of the quarterly report of the Cronos Group (CRON). The company's financial results for the reporting financial quarter were significantly worse than market expectations. So, in particular, the company unexpectedly reported a loss of $8.8 million, after which major analysts worsened their recommendations on these securities to “sell” from “hold”.
At the same time, after having somewhat digested this information, this segment of the market again shot upward as part of the correction. An additional reason for optimism was the Ernst & Young forecast that by 2025, every fifth Canadian adult will be using marijuana, spending an average of 1.7 thousand dollars a year for this purpose.
In turn, the company Tilray Inc. (TLRY) promised to strengthen its team by attracting experienced financial experts to prepare sound financial statements and strengthen internal financial control.
According to financial scouts, in the coming days, shares of Canadian cannabis producers will continue their upward trend. For example, Cronos shares could rise to $19, Tilray - up to $66.5, Canopy Growth (CGC) - up to $43-43.5, Aurora Cannabis (ACB) - up to $9, Aphria (APHA) - up to $9,5 dollars.
Shares of Canadian cannabis manufacturing companies on Friday mostly rose as part of the correction to a rather serious fall, which followed the publication of the quarterly report of the Cronos Group (CRON). The company's financial results for the reporting financial quarter were significantly worse than market expectations. So, in particular, the company unexpectedly reported a loss of $8.8 million, after which major analysts worsened their recommendations on these securities to “sell” from “hold”.
At the same time, after having somewhat digested this information, this segment of the market again shot upward as part of the correction. An additional reason for optimism was the Ernst & Young forecast that by 2025, every fifth Canadian adult will be using marijuana, spending an average of 1.7 thousand dollars a year for this purpose.
In turn, the company Tilray Inc. (TLRY) promised to strengthen its team by attracting experienced financial experts to prepare sound financial statements and strengthen internal financial control.
According to financial scouts, in the coming days, shares of Canadian cannabis producers will continue their upward trend. For example, Cronos shares could rise to $19, Tilray - up to $66.5, Canopy Growth (CGC) - up to $43-43.5, Aurora Cannabis (ACB) - up to $9, Aphria (APHA) - up to $9,5 dollars.
European investors still on edge
Despite European investors' hope for a quick resolution to the trade conflict between China and the US, the future of the global economy and Brexit are still weighing on their minds.
Most market participants are hoping that both sides can reach a final agreement to end the current stand off. According to rumours we are hearing on the market, the countries' representative made some serious progress at the most recent round of talks and a final agreement is now close at hand.
Meanwhile, investors have been seriously concerned about the future growth of the global economy following the release of weak economic data from both the US and the eurozone.
Italy's projected GDP growth for this yer has now been lowered from 0.9% to 0%.
It is predicted that this indicator will only enter positive growth in 2020, when it is seen up 0.4% against 2019.
In other news, European investors are waiting for further developments in relation to Brexit after British MPs voted, as many anticipated, to postpone the date of the UK's departure from the EU.
At the same time, the UK parliament was unable to find majority support for any of the eight Brexit options currently on the table.
Despite European investors' hope for a quick resolution to the trade conflict between China and the US, the future of the global economy and Brexit are still weighing on their minds.
Most market participants are hoping that both sides can reach a final agreement to end the current stand off. According to rumours we are hearing on the market, the countries' representative made some serious progress at the most recent round of talks and a final agreement is now close at hand.
Meanwhile, investors have been seriously concerned about the future growth of the global economy following the release of weak economic data from both the US and the eurozone.
Italy's projected GDP growth for this yer has now been lowered from 0.9% to 0%.
It is predicted that this indicator will only enter positive growth in 2020, when it is seen up 0.4% against 2019.
In other news, European investors are waiting for further developments in relation to Brexit after British MPs voted, as many anticipated, to postpone the date of the UK's departure from the EU.
At the same time, the UK parliament was unable to find majority support for any of the eight Brexit options currently on the table.
Cannabis stocks could rise on Cronos quarterly report
Shares in Canadian cannabis producers are trading mixed this Tuesday as the market awaits Cronos Group’s Q4 2018 report.
In the run-up to the release of Cronos’s final quarterly report for 2018, the company’s shares are rising and currently lead their sector, which would suggest that investors are anticipating positive results from the Canadian firm.
Still, the market’s growth has been somewhat restrained following reports that New Jersey has postponed a crucial vote on cannabis legalisation. The Garden State is at the forefront of the charge for legalisation in the US and is thus regarded as a barometer of the movement’s overall momentum.
Canopy Growth’s (CGC) shares are not faring particularly well this week despite the announcement that the company has been granted a license by the Canadian government to cultivate cannabis in the province of New Brunswick. The producer plans to grow approximately 5,000 kg of cannabis a year at this new facility, with the first harvest expected in just six months’ time.
Our financial scouts believe that future share movements in this sector will be largely determined by Cronos’s financial results. If they reveal strong indicators, then the company’s share price could reach $21-21.5, while Aphria’s (APHA) could rise to $10. Meanwhile, shares in Aurora Cannabis (ACB) could hit $10.5, with Canopy Growth and Tilray similarly rising to $44.5-45 and $68-68.5 respectively.
Shares in Canadian cannabis producers are trading mixed this Tuesday as the market awaits Cronos Group’s Q4 2018 report.
In the run-up to the release of Cronos’s final quarterly report for 2018, the company’s shares are rising and currently lead their sector, which would suggest that investors are anticipating positive results from the Canadian firm.
Still, the market’s growth has been somewhat restrained following reports that New Jersey has postponed a crucial vote on cannabis legalisation. The Garden State is at the forefront of the charge for legalisation in the US and is thus regarded as a barometer of the movement’s overall momentum.
Canopy Growth’s (CGC) shares are not faring particularly well this week despite the announcement that the company has been granted a license by the Canadian government to cultivate cannabis in the province of New Brunswick. The producer plans to grow approximately 5,000 kg of cannabis a year at this new facility, with the first harvest expected in just six months’ time.
Our financial scouts believe that future share movements in this sector will be largely determined by Cronos’s financial results. If they reveal strong indicators, then the company’s share price could reach $21-21.5, while Aphria’s (APHA) could rise to $10. Meanwhile, shares in Aurora Cannabis (ACB) could hit $10.5, with Canopy Growth and Tilray similarly rising to $44.5-45 and $68-68.5 respectively.
European Investors are worried about the perspectives of global economic development and Brexit.
European stock markets will be under hard pressure due to investors being nervous about further perspectives for development of the European economy as well as of global economy in general. Such concerns became really serious after the Eurozone and USA economic statistics were published. A serious deterioration in terms of forecasts on further perspectives for the world economy were given by various institutions and organisations.
Another topic for active discussions and increased concerns of market players is still related to the dynamics of profitability of US treasury bonds. The recent movements of the profitability curve make the investors think that a recession might take place in the US economy during this year.
Apart from this, the trading participants prefer to hold back from risky investments awaiting for another round of trading negotiations between the USA and China, that are scheduled for the 28th of March. In the beginning of April representatives of China are also going to pay a return visit to Washington.
Besides all the above-mentioned facts, the worries with regards to the Brexit deal also influence investment sentiments negatively. After the European leaders postponed the date when Great Britain is supposed to leave the EU for several weeks beyond the 29th of March date, the question about the scenario of this process still remains open.
European stock markets will be under hard pressure due to investors being nervous about further perspectives for development of the European economy as well as of global economy in general. Such concerns became really serious after the Eurozone and USA economic statistics were published. A serious deterioration in terms of forecasts on further perspectives for the world economy were given by various institutions and organisations.
Another topic for active discussions and increased concerns of market players is still related to the dynamics of profitability of US treasury bonds. The recent movements of the profitability curve make the investors think that a recession might take place in the US economy during this year.
Apart from this, the trading participants prefer to hold back from risky investments awaiting for another round of trading negotiations between the USA and China, that are scheduled for the 28th of March. In the beginning of April representatives of China are also going to pay a return visit to Washington.
Besides all the above-mentioned facts, the worries with regards to the Brexit deal also influence investment sentiments negatively. After the European leaders postponed the date when Great Britain is supposed to leave the EU for several weeks beyond the 29th of March date, the question about the scenario of this process still remains open.
Cannabis stocks could rally on good corporate news
Shares in Canada's biggest cannabis producing companies fell on Friday despite the market receiving several pieces of positive news.
Among these was the announcement by Canopy Growth (CGC) that it had acquired cannabis producer AgriNextUSA in a deal which Canopy's senior management believes will help the company expand its US business. This move comes shortly after another intra-sector acquisition saw the Canadian outfit add Colorado-based Ebbu to its portfolio.
Under the terms of the deal, AgriNextUSA's CEO will join the Canopy Growth team as its strategic advisor.
Then there was one final bit of good news for the market in the form of reports that Curaleaf has secured a deal that will see its products sold in hundreds of CVS Health stores across 10 US states.
Many financial scouts believe that these recent positive reports could bring a return to growth for stocks in this sector. Despite the recent decline, they are predicting unit share price increases for all major companies in this sector over the medium-to-short term, with Canopy Growth set to rise $47, Aurora Canabis (ACB) to $10 and Tilray (TLRY) to $71. Meanwhile, Aphria (APHA) is tipped to rise to $11, while Cronos (CRON) is seen up to $21.
Shares in Canada's biggest cannabis producing companies fell on Friday despite the market receiving several pieces of positive news.
Among these was the announcement by Canopy Growth (CGC) that it had acquired cannabis producer AgriNextUSA in a deal which Canopy's senior management believes will help the company expand its US business. This move comes shortly after another intra-sector acquisition saw the Canadian outfit add Colorado-based Ebbu to its portfolio.
Under the terms of the deal, AgriNextUSA's CEO will join the Canopy Growth team as its strategic advisor.
Then there was one final bit of good news for the market in the form of reports that Curaleaf has secured a deal that will see its products sold in hundreds of CVS Health stores across 10 US states.
Many financial scouts believe that these recent positive reports could bring a return to growth for stocks in this sector. Despite the recent decline, they are predicting unit share price increases for all major companies in this sector over the medium-to-short term, with Canopy Growth set to rise $47, Aurora Canabis (ACB) to $10 and Tilray (TLRY) to $71. Meanwhile, Aphria (APHA) is tipped to rise to $11, while Cronos (CRON) is seen up to $21.
European investors are worried about Brexit and are pretty skeptical when it comes to FRS policy.
European stock markets are nervous about the further perspective of Great Britain leaving Eurozone. It is still not clear whether it will be a Brexit with arrangements or not and when it will take place.
Brexit without a deal might seriously impact not just the British economy, but the Economy of the EU in general and some of its countries in particular. For example, Spain has assessed that in a worst case scenario, Brexit will cost the Spanish economy 10 bln euros. The British Chamber of Commerce has already downgraded its GDP growth forecast for 2019 from previously expected 1,3% to 1,2% against the backdrop of the continuing uncertainty about Brexit.
Meanwhile, the fact that Great Britain and the EU have coordinated a draft of the possible future memorandum of understanding that stipulates the information exchange between the regulatory bodies of the parties in the case of Brexit without a deal still looks positive to investors. At the same time, market players still hope that the agreement between the parties will be reached. Right now the EU still has to announce its decision with regards to the proposal of the British prime minister Theresa May to postpone the Brexit date to the 30th of June.
Apart from the events in the region, European investors have also paid their attention to the rhetoric of FRS of the USA. Despite of the fact that the financial market on the USA has preserved its basic interest rate in March and doesn't promise any further increases in the nearest future, financial scouts still point out that market players preserve their skepticism about the further politics of FED.
European stock markets are nervous about the further perspective of Great Britain leaving Eurozone. It is still not clear whether it will be a Brexit with arrangements or not and when it will take place.
Brexit without a deal might seriously impact not just the British economy, but the Economy of the EU in general and some of its countries in particular. For example, Spain has assessed that in a worst case scenario, Brexit will cost the Spanish economy 10 bln euros. The British Chamber of Commerce has already downgraded its GDP growth forecast for 2019 from previously expected 1,3% to 1,2% against the backdrop of the continuing uncertainty about Brexit.
Meanwhile, the fact that Great Britain and the EU have coordinated a draft of the possible future memorandum of understanding that stipulates the information exchange between the regulatory bodies of the parties in the case of Brexit without a deal still looks positive to investors. At the same time, market players still hope that the agreement between the parties will be reached. Right now the EU still has to announce its decision with regards to the proposal of the British prime minister Theresa May to postpone the Brexit date to the 30th of June.
Apart from the events in the region, European investors have also paid their attention to the rhetoric of FRS of the USA. Despite of the fact that the financial market on the USA has preserved its basic interest rate in March and doesn't promise any further increases in the nearest future, financial scouts still point out that market players preserve their skepticism about the further politics of FED.
Correction sees cannabis stocks fall after rally on good corporate news runs course
Shares in most major Canadian cannabis producers are now undergoing a correction following moderate-to-strong growth in response to Hexo posting better Q2 earnings (up to $16.2 million).
As the company itself acknowledges, it owes a large part of this success to the significant rise in demand within the recreational cannabis sector as a whole. Just a day earlier, it was another positive development for Hexo that helped to buoy the market as the company announced plans to acquire Newstrike Brands Ltd. — a venture backed by former Canadian rock group The Tragically Hip — in a deal worth an estimated CAD 263 million (USD 198 million). Once it completes the acquisition, Hexo will gain close to 2 million square feet of additional production space.
Finally, the market received one last piece of good news this week in the form of Aurora Cannabis's (ACB) announcement that major investor Nelson Peltz had joined the company as a senior advisor.
In conclusion, it is likely that this downward correction will be sustained over the medium-to-short term, as is to be expected after such a sharp rise. With this in mind, we can expect shares in the big Canadian producers to continue on their current trajectory, with Aurora Cannabis tipped to fall to $8, Canopy Growh (CGC) to $45, Tilray (TLRY) to $72, Aphria to $12 and Cronos (CRON) to $20.
Shares in most major Canadian cannabis producers are now undergoing a correction following moderate-to-strong growth in response to Hexo posting better Q2 earnings (up to $16.2 million).
As the company itself acknowledges, it owes a large part of this success to the significant rise in demand within the recreational cannabis sector as a whole. Just a day earlier, it was another positive development for Hexo that helped to buoy the market as the company announced plans to acquire Newstrike Brands Ltd. — a venture backed by former Canadian rock group The Tragically Hip — in a deal worth an estimated CAD 263 million (USD 198 million). Once it completes the acquisition, Hexo will gain close to 2 million square feet of additional production space.
Finally, the market received one last piece of good news this week in the form of Aurora Cannabis's (ACB) announcement that major investor Nelson Peltz had joined the company as a senior advisor.
In conclusion, it is likely that this downward correction will be sustained over the medium-to-short term, as is to be expected after such a sharp rise. With this in mind, we can expect shares in the big Canadian producers to continue on their current trajectory, with Aurora Cannabis tipped to fall to $8, Canopy Growh (CGC) to $45, Tilray (TLRY) to $72, Aphria to $12 and Cronos (CRON) to $20.
Cannabis stocks continue to rise on reports of US legalisation plans
Libertex notes that shares in major Canadian cannabis producers are rising after politicians in New Jersey made public their plans to legalise recreational cannabis use for adults over the age of 21. It has also been suggested that US local authorities will be permitted to tax cannabis producers operating on their territory at a rate of 2% of the companies' total earnings.
There was another welcome development for the sector in the form of Harvest Health & Recreation's announcement that it is to acquire competitor Verano Holdings in a deal that will see the purchasing company gain a further 30 retail outlets and 7 production facilities. According to its own projections, Harvest Health expects to own 70 retail locations, 13 farms and 13 production facilities by the end of the year.
Our financial scouts are convinced that the recent wave of positive market news will be sufficient to buoy cannabis stocks over the short-to-medium term. Their predictions include share price increases for all the major producers, with Tilray (TLRY) set to rise to $72.5-73, Canopy Growth (CGC) to $47-47.5 and Aurora Cannabis (ACB) to $8-8.5. Meanwhile, they expect shares in Cronos Group (CRON) and Aphria Inc (APHA) to reach $21.5-22 and $10 respectively.
Libertex notes that shares in major Canadian cannabis producers are rising after politicians in New Jersey made public their plans to legalise recreational cannabis use for adults over the age of 21. It has also been suggested that US local authorities will be permitted to tax cannabis producers operating on their territory at a rate of 2% of the companies' total earnings.
There was another welcome development for the sector in the form of Harvest Health & Recreation's announcement that it is to acquire competitor Verano Holdings in a deal that will see the purchasing company gain a further 30 retail outlets and 7 production facilities. According to its own projections, Harvest Health expects to own 70 retail locations, 13 farms and 13 production facilities by the end of the year.
Our financial scouts are convinced that the recent wave of positive market news will be sufficient to buoy cannabis stocks over the short-to-medium term. Their predictions include share price increases for all the major producers, with Tilray (TLRY) set to rise to $72.5-73, Canopy Growth (CGC) to $47-47.5 and Aurora Cannabis (ACB) to $8-8.5. Meanwhile, they expect shares in Cronos Group (CRON) and Aphria Inc (APHA) to reach $21.5-22 and $10 respectively.
European markets expected to fall on fears of a global economic slowdown
Europe's stock markets look set to remain subdued over the short-to-medium term on fears of a global economic slowdown and particularly poor economic indicators coming out of the Old Continent. The outlook only worsened following recent comments from the European Central Bank (ECB) as the regulator lowered its eurozone GDP growth forecasts for 2019 from 1.7% to 1.1%, also scaling down its 2020 projections from 1.7% to 1.6%. European stocks then took another hit following the publication of seriously weak Chinese exports data revealing an annualised fall of 20.7% for February. This comes after the previous month's numbers showed a 9.1% rise in January. Of course, these figures are a knock-on effect of the Asian giant's ongoing trade conflict with the USA.
The bad news continued for the European and world markets with poor labour market data from the US pointing to a deterioration of the economic situation in the country. All of the above factors explain why many investors are concerned about a potential slowdown in the global economy. Looking now to regional news, we received reports that the Sovereign Wealth Fund of Norway, which is responsible for managing the Nordic nation's assets, is set to sell its oil and gas shares under instructions from the country's Ministry of Finance. Meanwhile, Europe continues its wait for a definitive solution to the issue of Brexit.
Europe's stock markets look set to remain subdued over the short-to-medium term on fears of a global economic slowdown and particularly poor economic indicators coming out of the Old Continent. The outlook only worsened following recent comments from the European Central Bank (ECB) as the regulator lowered its eurozone GDP growth forecasts for 2019 from 1.7% to 1.1%, also scaling down its 2020 projections from 1.7% to 1.6%. European stocks then took another hit following the publication of seriously weak Chinese exports data revealing an annualised fall of 20.7% for February. This comes after the previous month's numbers showed a 9.1% rise in January. Of course, these figures are a knock-on effect of the Asian giant's ongoing trade conflict with the USA.
The bad news continued for the European and world markets with poor labour market data from the US pointing to a deterioration of the economic situation in the country. All of the above factors explain why many investors are concerned about a potential slowdown in the global economy. Looking now to regional news, we received reports that the Sovereign Wealth Fund of Norway, which is responsible for managing the Nordic nation's assets, is set to sell its oil and gas shares under instructions from the country's Ministry of Finance. Meanwhile, Europe continues its wait for a definitive solution to the issue of Brexit.
Jump to: